牛牛AI助理已提取核心訊息
Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 3,760 shares of common stock on March 4, 2024. The transaction was executed in the open market at a price of $11.1212 per share, resulting in a total sale value of approximately $41,815.71. Following the sale, Matsuda Masaru's direct holdings in the company amount to 190,424 shares of common stock.
Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 3,760 shares of common stock on March 4, 2024. The transaction was executed in the open market at a price of $11.1212 per share, resulting in a total sale value of approximately $41,815.71. Following the sale, Matsuda Masaru's direct holdings in the company amount to 190,424 shares of common stock.
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的松田勝於2024年3月4日完成了3760股普通股的出售。該交易在公開市場上以每股11.1212美元的價格執行，總銷售價值約爲41,815.71美元。出售後，松田正直接持有的公司普通股爲190,424股。
與Arcutis Biotherapeutics, Inc. [ARQT] 相關的松田勝於2024年3月4日完成了3760股普通股的出售。該交易在公開市場上以每股11.1212美元的價格執行，總銷售價值約爲41,815.71美元。出售後，松田正直接持有的公司普通股爲190,424股。
有用
沒用